Part II: managing perioperative hyperglycemia in total hip and knee replacement surgeries
Florence Agos1, Casey Shoda2, Deborah Bransford3
1Orthopedic Surgery Unit, The Queen's Medical Center, Kamehameha 3 Makai, 1301 Punchbowl Street, Honolulu, HI 96813, USA; Surgical Short Stay Unit, The Queen's Medical Center, Kamehameha 3 Makai, 1301 Punchbowl Street, Honolulu, HI 96813, USA.
Abstract:
Perioperative hyperglycemia management is an important factor in reducing the risk of surgical site infections (SSIs) in all patients regardless of existing history of diabetes. Reduction of SSIs is one of the quality indicators reported by the National Healthcare Safety Networks of the Centers for Disease Control and Prevention (CDC). In 2009 and 2010, the orthopedic surgical unit had an increased number of SSIs above the CDC benchmark. This article describes the impact of an evidence-based practice standard for perioperative hyperglycemia management in the reduction of SSIs in patients having total hip and knee replacement surgery.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon
Hyperglycemia
Complications of Diabetes Mellitus
Hyperosmolar Hyperglycemic State


